These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4642922)

  • 1. [Determination of cholinesterase activity in animal tissues following treatment with reversible inhibitors].
    tonkopiĭ VD; Savateev NV; Brestkin AP; Panov AN
    Dokl Akad Nauk SSSR; 1972 Nov; 207(3):736-8. PubMed ID: 4642922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of reversible inhibitors on the thermal denaturation of cholinesterases].
    Tonkopiĭ VD; Padinker EB
    Biull Eksp Biol Med; 1975 Apr; 79(4):51-2. PubMed ID: 1191768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between acetylcholine and cholinesterase activity in the brain following organophosphorus cholinesterase inhibitors.
    Awad O
    Arzneimittelforschung; 1972 Nov; 22(11):1926-7. PubMed ID: 4679066
    [No Abstract]   [Full Text] [Related]  

  • 4. N-(3,4,5-trimethoxyphenylethyl)-aziridine--a mescaline derivative: interaction with cholinesterases in vitro.
    Patocka J; Hrdina V; Zámocký J
    Act Nerv Super (Praha); 1989 Jun; 31(2):132-3. PubMed ID: 2800949
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between cholinesterase activity and brain permeability to barbitone.
    Rosić N; Milosević MP
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):302-7. PubMed ID: 6047617
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of galanthamine as a reversible inhibitor of cholinesterase].
    Vasilenko ET; Tonkopiĭ VD
    Biokhimiia; 1974; 39(4):701-3. PubMed ID: 4441566
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interaction of reversible inhibitors with the catalytic centers and allosteric sites of cholinesterases].
    Tonkopiĭ VD; Prozorovskiĭ VB; Suslova IM
    Biull Eksp Biol Med; 1976 Aug; 82(8):947-50. PubMed ID: 1026294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
    Geerts H; Guillaumat PO; Grantham C; Bode W; Anciaux K; Sachak S
    Brain Res; 2005 Feb; 1033(2):186-93. PubMed ID: 15694923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The specificity of the interaction of the cholinesterases in Far Eastern squid and certain vertebrates with reversible inhibitors].
    Rozengart EV; Viniar TN; Kovalev NN; Khovanskikh AE
    Zh Evol Biokhim Fiziol; 1988; 24(5):679-85. PubMed ID: 3265246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterase activity in plasma, red blood cells, muscle, and brain of dogs following repeated exposure to Spotton (fenthion).
    Sundlof SF; Clemmons RM; Meyer DJ; Rappaport JJ; Fossler ME; Hubbell J
    Vet Hum Toxicol; 1984 Apr; 26(2):112-7. PubMed ID: 6730296
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of cholinesterase from different sources by 3-diethylaminophenyl-N-methylcarbamate methiodide in vitro.
    Bajgar J; Patocka J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1983; 26(5):597-602. PubMed ID: 6599176
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of securinine and galanthamine on cholinesterase activity].
    Aoyagi Y; Maki Y; Yamazoe S
    Igaku To Seibutsugaku; 1965 Dec; 71(6):349-51. PubMed ID: 4380182
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of injection volume on parathion toxicity and plasma and brain cholinesterase inhibition.
    Koshakji RP; Cole J; Harbison RD
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):677-87. PubMed ID: 4750107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the in vivo influence of morphine on cholinesterase activity in various tissues].
    Rombach M; Royer R; Lamarche M
    C R Seances Soc Biol Fil; 1967 Jul; 161(2):424-7. PubMed ID: 4229154
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes of cholinesterase activities in the plasma and some tissues following administration of L-carnitine and galanthamine to rats.
    Bajgar J; Bartosova L; Fusek J; Svoboda Z; Herink J; Kvetina J; Palicka V; Zivny P; Blaha V
    Neurosci Lett; 2007 Jan; 411(3):212-6. PubMed ID: 17125927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Inhibition of cholinesterase activity by two methylacridinium compounds.
    Bradshaw D; Butchart GA; Hemsworth BA; Stevens MF
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():123P. PubMed ID: 4156718
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of physostigmine on cholinesterase activity in different parts of rat brain.
    Osman MY; Abdel Tawab SM; Sharaf IA
    Arzneimittelforschung; 1995 Jun; 45(6):663-5. PubMed ID: 7646566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 6beta-D-glucosyl and 6-nitroxy (-)-galanthamine derivatives as acetylcholinesterase inhibitors.
    Perissutti E; Fiorino F; Severino B; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
    Pharmazie; 2007 Jun; 62(6):403-5. PubMed ID: 17663183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacological characteristics of the new anticholinesterase drug aminostigmine].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Shchemeleva NI
    Eksp Klin Farmakol; 1992; 55(1):13-6. PubMed ID: 1305425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of galantamine on acetylcholinesterase and butyrylcholinesterase activities in the presence of L-carnitine in rat selected brain and peripheral tissues.
    Svoboda Z; Kvetina J; Kunesová G; Herink J; Bajgar J; Bartosová L; Zivný P; Palicka V
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():183-6. PubMed ID: 17159811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.